Table 3. Association of CMM with cardiovascular disease mortality among hypertensive patients in the China National Survey for Determinants of Detection and Treatment Status of Hypertensive Patients with Multiple Risk Factors study.

	Mortality	Crude mortality rate, number of per 1000 person-years (95% CI)	Crude model			Model 1			Model 2
			HR (95% CI)	P-value		HR (95% CI)	P-value		HR (95% CI)	P-value
Model 1: adjusted for age, sex, education level, occupation, current smoking, current drinking, exercise, and waist circumference. Model 2: adjusted for variables in Model 1 plus the ideal use of medications. CMM: cardiometabolic multimorbidity.
Total	183 (3.7%)	3.63 (3.12–4.19)
Hypertension only	23 (1.9%)	1.91 (1.21–2.87)	Reference	Reference		Reference	Reference		Reference	Reference
Hypertension & 1 CMM	49 (2.5%)	2.51 (1.85–3.31)	1.31 (0.80–2.15)	0.280		1.16 (0.70–1.93)	0.570		1.19 (0.72–1.99)	0.500
Hypertension & 2 CMMs	56 (4.3%)	4.32 (3.26–5.61)	2.27 (1.40–3.69)	< 0.001		1.69 (1.02–2.79)	0.040		1.83 (1.10–3.06)	0.020
Hypertension & 3+ CMMs	55 (9.1%)	9.38 (7.07–12.21)	4.97 (3.05–8.08)	< 0.001		2.92 (1.74–4.89)	< 0.001		3.22 (1.89–5.48)	< 0.001